摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tetra-tert-butyl 4,4',4'',4'''-(((((6-chloro-1,3,5-triazine-2,4-diyl)bis(piperidine-1,4-diyl))bis(propane-3,1-diyl))bis(piperidine-4,1-diyl))bis(1,3,5-triazine-6,2,4-triyl))tetrakis(piperazine-1-carboxylate) | 1447919-00-7

中文名称
——
中文别名
——
英文名称
tetra-tert-butyl 4,4',4'',4'''-(((((6-chloro-1,3,5-triazine-2,4-diyl)bis(piperidine-1,4-diyl))bis(propane-3,1-diyl))bis(piperidine-4,1-diyl))bis(1,3,5-triazine-6,2,4-triyl))tetrakis(piperazine-1-carboxylate)
英文别名
——
tetra-tert-butyl 4,4',4'',4'''-(((((6-chloro-1,3,5-triazine-2,4-diyl)bis(piperidine-1,4-diyl))bis(propane-3,1-diyl))bis(piperidine-4,1-diyl))bis(1,3,5-triazine-6,2,4-triyl))tetrakis(piperazine-1-carboxylate)化学式
CAS
1447919-00-7
化学式
C71H116ClN21O8
mdl
——
分子量
1427.29
InChiKey
SFZONFUDWXCCPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    9.73
  • 重原子数:
    101.0
  • 可旋转键数:
    16.0
  • 环数:
    11.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    260.09
  • 氢给体数:
    0.0
  • 氢受体数:
    25.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Design, Synthesis and Biological Assessment of a Triazine Dendrimer with Approximately 16 Paclitaxel Groups and 8 PEG Groups
    作者:Changsuk Lee、Su-Tang Lo、Jongdoo Lim、Viviana C. P. da Costa、Saleh Ramezani、Orhan K. Öz、Giovanni M. Pavan、Onofrio Annunziata、Xiankai Sun、Eric E. Simanek
    DOI:10.1021/mp400290u
    日期:2013.12.2
    The synthesis and characterization of a generation three triazine dendrimer that displays a phenolic group at the core for labeling, up to eight 5 kDa PEG chains for solubility, and 16 paclitaxel groups is described. Three different diamine linkers-dipiperidine trismethylene, piperazine, and aminomethylpiperidine-were used within the dendrimer. To generate the desired stoichiometric ratio of 8 PEG chains to 16 paclitaxel groups, a monochlorotriazine was prepared with two paclitaxel groups attached through their 2'-hydroxyls using a linker containing a labile disulfide. This monochlorotriazine was linked to a dichlorotriazine with aminomethylpiperidine. The resulting dichlorotriazine bearing two paclitaxel groups could be reacted with the eight amines of the dendrimer. NMR and MALDI-TOF confirm successful reaction. The eight monochlorotriazines of the resulting material are used as the site for PEGylation affording the desired 2:1 stoichiometry. The target and intermediates were amenable to characterization by H-1 and C-13 NMR, and mass spectrometry. Analysis revealed that 16 paclitaxel groups were installed along with 5-8 PEG chains. The final construct is 63% PEG, 22% paclitaxel, and 15% triazine dendrimer. Consistent with previous efforts and computational models, 5 kDa PEG groups were essential for making the target water-soluble. Molecular dynamics simulations showed a high degree of hydration of the core, and a radius of gyration of 2.8 +/- 0.2 nm. The hydrodynamic radius of the target was found to be 15.8 nm by dynamic light scattering, an observation indicative of aggregation. Drug release studies performed in plasma showed slow and identical release in mouse and rat plasma (8%, respectively). SPECT/CT imaging was used to follow biodistribution and tumor uptake. Using a two component model, the elimination and distribution half-lives were 2.65 h and 38.2 h, respectively. Compared with previous constructs, this dendrimer persists in the vasculature longer (17.33 +/- 0.88% ID/g at 48 h postinjection), and showed higher tumor uptake. Low levels of dendrimer were observed in lung, liver, and spleen (similar to 6% ID/g). Tumor saturation studies of small prostate cancer tumors (PC3) suggest that saturation occurs at a dose between 23.2 mg/kg and 70.9 mg/kg.
查看更多